Hims & Hers Health (HIMS) Other Non-Current Liabilities (2020 - 2026)
Hims & Hers Health (HIMS) posted Other Non-Current Liabilities of $12.9 million for Q1 2026, up 9.93% sequentially from $11.7 million in Q4 2025, and up 428.65% YoY from $2.4 million in Q1 2025.
Hims & Hers Health (HIMS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Other Non-Current Liabilities for 7 years, with the latest figure at $12.9 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 428.65% year-over-year to $12.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (up 428.65% YoY) and the FY2025 annual result came in at $11.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities rose to $12.9 million in Q1 2026 per HIMS's latest filing, from $11.7 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $12.9 million in Q1 2026 and troughed at $21000.0 in Q1 2024.
- A 5-year average of $2.8 million and a median of $371000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities slumped 98.45% in 2022, then soared 11519.05% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $35000.0 in 2022, then slumped by 37.14% to $22000.0 in 2023, then changed by 0.0% to $22000.0 in 2024, then jumped by 53236.36% to $11.7 million in 2025, then increased by 9.93% to $12.9 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $12.9 million, $11.7 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.66 Mn |
| Mar 31, 2026 | 12.90 Mn |
| Dec 31, 2025 | 11.73 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 84,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 249,000.00 |
| Jun 30, 2022 | 371,000.00 |
| Mar 31, 2022 | 517,000.00 |
| Dec 31, 2021 | 629,000.00 |
| Sep 30, 2021 | 11.20 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 33.37 Mn |
| Dec 31, 2020 | 381,000.00 |